← Back
$LGND All transactions

LIGAND PHARMACEUTICALS INC

J

$ Value

$21K

Shares

233

Price

$91

Filed

Jul 2

Insider

Name

Reardon Andrew

Title

CLO & Secretary

CIK

0001950232

Roles

Officer

Transaction Details

Transaction Date

2025-06-30

Code

J

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

32,136

Footnotes

These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Filing Info

Accession No.

0002001011-25-000052

Form Type

4

Issuer CIK

0000886163

Reardon Andrew's History

Date Ticker Type Value
2026-04-01 LGND M $261K
2026-04-01 LGND $91K
2026-04-01 LGND $260K
2026-04-01 LGND $249K
2026-04-01 LGND $141K
2026-04-01 LGND $196K
2026-04-01 LGND $69K
2026-04-01 LGND M $0
2026-03-02 LGND A $0
2026-03-02 LGND A $0

Other Insiders at LGND (90d)

Insider Bought Sold Last
LAMATTINA JOHN L $434K 2026-03-06
KOZARICH JOHN W $94K 2026-04-01
Davis Todd C
Chief Executive Officer
2026-03-02
Sabba Stephen L $208K 2026-03-23
Espinoza Octavio
Chief Financial Officer
2026-03-02
Reardon Andrew
CLO & Secretary
$1.0M 2026-04-01